AbbVie
ABBV
ABBV
1,690 hedge funds and large institutions have $68.3B invested in AbbVie in 2016 Q4 according to their latest regulatory filings, with 147 funds opening new positions, 648 increasing their positions, 668 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
2% less capital invested
Capital invested by funds: $69.4B → $68.3B (-$1.08B)
3% less repeat investments, than reductions
Existing positions increased: 648 | Existing positions reduced: 668
1.09% less ownership
Funds ownership: 68.28% → 67.19% (-1.1%)
Holders
1,690
Holding in Top 10
85
Calls
$1.06B
Puts
$1.04B
Top Buyers
| 1 | +$836M | |
| 2 | +$426M | |
| 3 | +$188M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$169M |
| 5 |
Asset Management One
Tokyo,
Japan
|
+$141M |
Top Sellers
| 1 | -$773M | |
| 2 | -$383M | |
| 3 | -$313M | |
| 4 |
JP Morgan Chase
New York
|
-$237M |
| 5 |
MTB
Mizuho Trust & Banking
Tokyo,
Japan
|
-$163M |